OpenAI launched a program Thursday to put its biology model in the hands of vetted developers building defensive tools. Through the new Rosalind Biodefense initiative, the company sponsors free API access to GPT-Rosalind for researchers, public health teams, and mission-driven groups working on pandemic preparedness.
Eligible applicants span academic, nonprofit, and government labs, plus small specialized startups. OpenAI covers the cost and provides launch support. Approved projects can target epidemiological modeling, early detection, biosurveillance, and medical countermeasure development, per the application form. Proposals get reviewed on a rolling basis.
GPT-Rosalind arrived in April as a research preview, built to reason about molecules, proteins, genes, and disease mechanisms. OpenAI named it after Rosalind Franklin, whose X-ray work helped reveal DNA's structure. The goal, the company says, is moving faster from hypothesis to experiment, though that framing sits alongside an obvious tension: the same biology models that aid defense carry dual-use risk. OpenAI, Anthropic, and outside researchers have warned repeatedly about AI-driven bioweapons.
Early collaborators include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the vaccine group CEPI. Access stays gated behind a trusted-developer vetting structure rather than opening to anyone. The program is open to qualified applicants globally, and OpenAI says it expects to keep expanding how government partners can use the model over time.
Bottom Line
OpenAI is giving vetted biodefense teams free GPT-Rosalind API access, with early partners including Lawrence Livermore and Johns Hopkins APL.
Quick Facts
- Program name: Rosalind Biodefense
- Model: GPT-Rosalind, introduced April 2026 as research preview
- Access: free sponsored API use for vetted developers
- Early partners: Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, CEPI
- Eligibility: academic, nonprofit, government labs and small specialized startups, open globally
